Finanzwire Finanzwire
Basculer en Français
11384 Companies
253058 Keywords
182715 Articles
138802 Press releases
Headlines Articles Press releases Novigenix Remove
  1. Home
  2. Companies
  3. Novigenix
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/17/2024 at 08:00, 2 years 10 months ago

    Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling

    Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes.
    Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
    Logo of Novigenix
Accesswire
  • Published on 11/20/2026 at 15:00, 11 hours 12 minutes ago

    Jaguar Health, Inc. Announces Reverse Stock Split

  • Published on 11/20/2026 at 14:50, 11 hours 22 minutes ago

    Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture

  • Published on 11/20/2026 at 14:00, 12 hours 12 minutes ago

    Dateline appoints Tony Ferguson as Acting Chairman

  • Published on 11/20/2026 at 13:30, 12 hours 42 minutes ago

    Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec

  • Published on 11/20/2026 at 13:30, 12 hours 42 minutes ago

    Alset AI Closes Non-Brokered Private Placement Offering

View all ACCESSWIRE
EQS Group
  • Published on 11/20/2026 at 23:45, 2 hours 27 minutes ago

    APEC CEO Summit 2026 Concludes Successfully in Shenzhen

  • Published on 11/20/2026 at 22:36, 3 hours 36 minutes ago

    Abivax Statement on Short Seller Report

  • Published on 11/20/2026 at 21:36, 4 hours 36 minutes ago

    EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders

  • Published on 11/20/2026 at 19:26, 6 hours 46 minutes ago

    EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack

  • Published on 11/20/2026 at 19:03, 7 hours 9 minutes ago

    EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group

View all EQS
Les Echos
  • Published on 11/20/2026 at 18:34, 7 hours 38 minutes ago

    Disclosure of transactions in own shares from November 16 to November 20, 2026

  • Published on 11/20/2026 at 17:35, 8 hours 37 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026

  • Published on 11/19/2026 at 19:00, 1 day 7 hours ago

    MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR

  • Published on 11/19/2026 at 08:30, 1 day 17 hours ago

    Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing

  • Published on 11/19/2026 at 08:00, 1 day 18 hours ago

    EXOR TO RAISE ITS STAKE IN BIOMÉRIEUX

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy